Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis—Report of Two Cases-Reference-Cited by-同舟云学术

Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis—Report of Two Cases

Published:2015-06-29 Issue:12 Volume:16 Page:14669-14676
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Rau Daniela,Lang Michael,Harth Andreas,Naumann Markus,Weber Frank,Tumani Hayrettin,Bayas Antonios

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/16/7/14669/pdf

Reference19 articles.

1. Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use

2. Alemtuzumab vs. interferon beta-1a in early multiple sclerosis;Coles;N. Engl. J. Med.,2008

3. Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

4. Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

5. Alemtuzumab Therapy for Multiple Sclerosis

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infektionen und Multiple Sklerose;Fortschritte der Neurologie · Psychiatrie;2024-05-08

2. Invasive Listeriosis in Europe – A Case Review;Advancements of Microbiology;2024-03-01

3. A safety review of current monoclonal antibodies used to treat multiple sclerosis;Expert Opinion on Drug Safety;2023-10-27

4. Latin American consensus recommendations on the risk of infections in people with multiple sclerosis treated with disease modifying drugs;Multiple Sclerosis and Related Disorders;2023-09

5. Listeriosis meningoencephalitis as an opportunistic disease in HIV infection;Journal Infectology;2023-04-19